Skip to main content

Table 5 One-way sensitivity analysis of ICER based on screening participation rate

From: Cost-effectiveness of family history-based colorectal cancer screening in Australia

Colonoscopy screening participation rate ICER COLO5vs. usual care ICER COLO10vs. usual care
  Life years gained per 1,000 persons ICER (AU$) Life years gained per 1,000 persons ICER (AU$)
10% 81 17,779 - Dominated
20% 346 9,108 148 7,835
30% 492 9,089 272 7,612
40% (reference) 561 9,842 361 8,619
50% 699 9,283 416 9,192
60% 717 10,095 476 9,863
70% 775 10,245 547 9,887
80% 824 10,279 609 9,949
90% 871 10,423 641 10,333
100% 880 11,139 722 10,384
  1. ICER: incremental cost-effectiveness ratio, iFOBT2: immunochemical faecal occult blood test, COLO5: colonoscopy screening every five years, COLO10: colonoscopy screening every ten years.
Back to article page